Category
Biosimilars
2 articles
PBSprice disclosure
Pharmaceutical Price Disclosure: How the PBS Cuts Work
Australia's price disclosure regime forces manufacturers to reveal real transaction prices, triggering mandatory PBS cuts. How it works, and reform priorities.
10 May 202612 min read
TGAmedicines regulation
TGA Reform Priorities for 2027: Faster Medicine Access
Australia's TGA faces pressure to modernise approvals, lift biosimilar uptake, close the digital therapeutics gap, and strengthen surveillance by 2027.
9 May 202612 min read